Fig. 1From: Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patientsPFS by disease status (a), donor type (c), and combining disease status and donor type (e), OS by disease status (b), donor type (d), and combining disease status and donor type (g)Back to article page